GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (FRA:PY30) » Definitions » Loans Receivable

Galderma Group AG (FRA:PY30) Loans Receivable : €0 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Loans Receivable?

Galderma Group AG's Loans Receivable for the quarter that ended in Jun. 2024 was €0 Mil.


Galderma Group AG Loans Receivable Historical Data

The historical data trend for Galderma Group AG's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Loans Receivable Chart

Galderma Group AG Annual Data
Trend
Loans Receivable

Galderma Group AG Semi-Annual Data
Jun23 Jun24
Loans Receivable - -

Galderma Group AG Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Galderma Group AG Loans Receivable Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Galderma Group AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines